Alvotech (ALVO) Research & Development (2021 - 2026)
Alvotech's (ALVO) quarterly Research & Development came in at -$21.9 million in Q2 2026, up 60.05% on a YoY basis from -$13.7 million in Q2 2025, and up 10.82% quarter-over-quarter from -$24.5 million in Q1 2026.
Analysis
Alvotech (ALVO) Research & Development (2021 - 2026) Analysis & Trends
Alvotech (ALVO) has reported Research & Development for 6 consecutive years, with -$21.9 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Research & Development rose 60.05% year-over-year to -$21.9 million; the trailing twelve-month figure through Jun 2026 stood at -$190.9 million (up 35.9% YoY), and the FY2025 full-year result was -$184.2 million, down 7.52% from the prior year.
- Research & Development climbed to -$21.9 million in Q2 2026 per ALVO's latest filing, from -$24.5 million in the prior quarter.
- Across five years, Research & Development topped out at $267.5 million in Q2 2022 and bottomed at -$210.8 million in Q1 2023.
- Historically, Research & Development has averaged -$74.3 million across 5 years, with a median of -$53.2 million in 2025.
- The sharpest annual moves came in 2023 and 2024: Research & Development sank 118.21% in 2023, then soared 76.35% in 2024.
- Over 5 years, Research & Development stood at -$180.6 million in 2022, then retreated by 16.72% to -$210.8 million in 2023, then gained by 18.74% to -$171.3 million in 2024, then surged by 45.78% to -$92.9 million in 2025, then surged by 76.47% to -$21.9 million in 2026.
- According to Business Quant data, Research & Development over the past three periods registered -$21.9 million, -$24.5 million, and -$92.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 970.00 Mn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 248.30 Mn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 60.90 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 39.02 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 173.00 Mn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 14.75 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | -21.86 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 22.16 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 10.66 Mn |
| 10 | NutriBand | 72.57 Mn | 69.15 Mn | 181,874.00 | 322,194.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -21.86 Mn |
| Mar 31, 2026 | -24.51 Mn |
| Dec 31, 2025 | -92.89 Mn |
| Sep 30, 2025 | -51.62 Mn |
| Jun 30, 2025 | -54.72 Mn |
| Mar 31, 2025 | -38.17 Mn |
| Dec 31, 2024 | -171.31 Mn |
| Sep 30, 2024 | -33.57 Mn |
| Jun 30, 2024 | -47.61 Mn |
| Mar 31, 2024 | -49.87 Mn |
| Dec 31, 2023 | -210.83 Mn |
| Aug 31, 2023 | -99.58 Mn |
| Jun 30, 2023 | -48.72 Mn |
| Mar 20, 2023 | -210.83 Mn |
| Dec 31, 2022 | -180.62 Mn |
| Aug 31, 2022 | -86.88 Mn |
| Jun 30, 2022 | 267.51 Mn |
| Mar 20, 2022 | -180.62 Mn |
| Dec 31, 2021 | -191.01 Mn |
| Sep 30, 2021 | -56.20 Mn |